AstraZeneca plans to invest Rs 250 crore to grow its Global Innovation and Technology Centre in India, bringing some 1,300 highly skilled roles by 2025 Read more
Asthma inhaler price cap in US may help pharma companies to secure more loyal customer base: GlobalData Read more
CALQUENCE plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial Read more
TAGRISSO reduces disease progression or death by 84 % in Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial Read more